Aymard Bernadette, Beghoura Rachid, Molina Thierry Jo
Centre de pathologie, 21, Rempart St-Thiébault, 57 000 Metz, France.
Nephrol Ther. 2011 Nov;7(6):479-87. doi: 10.1016/j.nephro.2011.02.001. Epub 2011 Mar 25.
We report the case of a 55-year-old male with renal failure as the initial manifestation of interstitial and focal infiltration of the kidneys by a small B-cell lymphoma. Since three years, this patient had a history of CLL with plasmocytic differentiation and was left untreated owing to stade A Binet classification. After chemotherapy, the lymphocytosis and the adenopathies disappear and the renal function improve. Infiltration of the kidneys by non-Hodgkin small B-cell lymphoma, including chronic lymphocytic leukaemia (CLL), is usually asymptomatic, fortuitously discovered at the time of an X-ray examination or at autopsy. Association with renal failure is extremely rare. We review the reported cases of renal failure associated with lymphomatous infiltration (13 cases of CLL and five cases of lymphoplasmocytic lymphoma kappa or lambda IgM), with the following conclusions: in most cases, renal insufficiency appears in a few months and significantly disappears after chemotherapy; the renal infiltrate is usually focal in lymphoplasmocytic lymphoma and rather massive and diffuse in CLL; the neoplastic feature of a small B-cell lymphoïd infiltrate may be difficult to determine: a poorly limited, monomorphous, CD20+ CD5+ lymphoid infiltrate is lymphomatous. In case of plasmocytic differentiation, it must be looked for kappa or lambda monotypy; the type of the lymphomatous infiltrate according to the WHO 2008 classification may be difficult to determine in a small sampling of renal tissue: the renal infiltrate must be compared, if possible, with a lymph node infiltrate. Owing to its bad prognosis, mantle cell lymphoma must be distinguished from other small B-cell lymphoma like CLL/small lymphocytic lymphoma, marginal zone lymphoma and lymphoplasmocytic lymphoma.
我们报告了一例55岁男性,以肾衰竭为首发表现,其肾脏存在小B细胞淋巴瘤的间质和局灶性浸润。三年来,该患者有慢性淋巴细胞白血病伴浆细胞分化病史,因Binet分期A期未接受治疗。化疗后,淋巴细胞增多和淋巴结病消失,肾功能改善。非霍奇金小B细胞淋巴瘤,包括慢性淋巴细胞白血病(CLL),对肾脏的浸润通常无症状,多在X线检查时偶然发现或在尸检时发现。与肾衰竭相关极为罕见。我们回顾了报道的与淋巴瘤浸润相关的肾衰竭病例(13例CLL和5例淋巴浆细胞性淋巴瘤κ或λ IgM),得出以下结论:在大多数情况下,肾功能不全在几个月内出现,化疗后明显消失;在淋巴浆细胞性淋巴瘤中,肾脏浸润通常为局灶性,而在CLL中则较为广泛和弥漫;小B细胞淋巴瘤浸润的肿瘤特征可能难以确定:界限不清、单形性、CD20+ CD5+的淋巴细胞浸润为淋巴瘤性。如有浆细胞分化,必须查找κ或λ单克隆性;根据2008年世界卫生组织分类,在肾脏组织的小样本中可能难以确定淋巴瘤浸润的类型:如有可能,则必须将肾脏浸润与淋巴结浸润进行比较。由于预后不良,套细胞淋巴瘤必须与其他小B细胞淋巴瘤,如CLL/小淋巴细胞淋巴瘤、边缘区淋巴瘤和淋巴浆细胞性淋巴瘤相鉴别。